Endolysosomal sorting of ubiquitylated caveolin-1 is regulated by VCP and UBXD1 and impaired by VCP disease mutations

Abstract

The AAA-ATPase VCP (also known as p97) cooperates with distinct cofactors to process ubiquitylated proteins in different cellular pathways1,2,3. VCP missense mutations cause a systemic degenerative disease in humans, but the molecular pathogenesis is unclear4,5. We used an unbiased mass spectrometry approach and identified a VCP complex with the UBXD1 cofactor, which binds to the plasma membrane protein caveolin-1 (CAV1) and whose formation is specifically disrupted by disease-associated mutations. We show that VCP–UBXD1 targets mono-ubiquitylated CAV1 in SDS-resistant high-molecular-weight complexes on endosomes, which are en route to degradation in endolysosomes6. Expression of VCP mutant proteins, chemical inhibition of VCP, or siRNA-mediated depletion of UBXD1 leads to a block of CAV1 transport at the limiting membrane of enlarged endosomes in cultured cells. In patient muscle, muscle-specific caveolin-3 accumulates in sarcoplasmic pools and specifically delocalizes from the sarcolemma. These results extend the cellular functions of VCP to mediating sorting of ubiquitylated cargo in the endocytic pathway and indicate that impaired trafficking of caveolin may contribute to pathogenesis in individuals with VCP mutations.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Figure 1: The VCP–UBXD1 chaperone complex binds to caveolin, and this interaction is specifically disrupted by IBMPFD-associated mutations in VCP.
Figure 2: VCP targets mono-ubiquitylated CAV1 in SDS-resistant oligomers.
Figure 3: Overexpression of VCP mutants or depletion of UBXD1 affect CAV1 transport to endolysosomes.
Figure 4: Chemical inhibition of VCP with DBeQ impairs CAV1 trafficking and delays degradation of the EGFR.
Figure 5: Mislocalization of caveolin in fibroblasts and muscle tissue of IBMPFD patients.

References

  1. 1

    Jentsch, S. & Rumpf, S. Cdc48 (p97): A ‘molecular gearbox’ in the ubiquitin pathway? Trends Biochem. Sci. 32, 6–11 (2007).

  2. 2

    Meyer, H. & Popp, O. Role(s) of Cdc48/p97 in mitosis. Biochem. Soc. Trans. 36, 126–130 (2008).

  3. 3

    Ye, Y. Diverse functions with a common regulator: ubiquitin takes command of an AAA ATPase. J. Struct. Biol. 156, 29–40 (2006).

  4. 4

    Watts, G. D. et al. Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nat. Genet. 36, 377–381 (2004).

  5. 5

    Weihl, C. C., Pestronk, A. & Kimonis, V. E. Valosin-containing protein disease: inclusion body myopathy with Paget’s disease of the bone and fronto-temporal dementia. Neuromuscul. Disord. 19, 308–315 (2009).

  6. 6

    Hayer, A. et al. Caveolin-1 is ubiquitinated and targeted to intraluminal vesicles in endolysosomes for degradation. J. Cell Biol. 191, 615–629 (2010).

  7. 7

    Jarosch, E., Geiss-Friedlander, R., Meusser, B., Walter, J. & Sommer, T. Protein dislocation from the endoplasmic reticulum–pulling out the suspect. Traffic 3, 530–536 (2002).

  8. 8

    Meyer, H. H., Shorter, J. G., Seemann, J., Pappin, D. & Warren, G. A complex of mammalian Ufd1 and Npl4 links the AAA-ATPase, p97, to ubiquitin and nuclear transport pathways. EMBO J. 19, 2181–2192 (2000).

  9. 9

    Schuberth, C. & Buchberger, A. UBX domain proteins: major regulators of the AAA ATPase Cdc48/p97. Cell Mol. Life Sci. 65, 2360–2371 (2008).

  10. 10

    Alexandru, G. et al. UBXD7 binds multiple ubiquitin ligases and implicates p97 in HIF1α turnover. Cell 134, 804–816 (2008).

  11. 11

    Tresse, E. et al. VCP/p97 is essential for maturation of ubiquitin-containing autophagosomes and this function is impaired by mutations that cause IBMPFD. Autophagy 6, 217–227 (2010).

  12. 12

    Ju, J. S. et al. Valosin-containing protein (VCP) is required for autophagy and is disrupted in VCP disease. J. Cell Biol. 187, 875–888 (2009).

  13. 13

    Janiesch, P. C. et al. The ubiquitin-selective chaperone CDC-48/p97 links myosin assembly to human myopathy. Nat. Cell Biol. 9, 379–390 (2007).

  14. 14

    Ju, J. S., Miller, S. E., Hanson, P. I. & Weihl, C. C. Impaired protein aggregate handling and clearance underlie the pathogenesis of p97/VCP associated disease. J. Biol. Chem. 283, 30289–30299 (2008).

  15. 15

    Fernandez-Saiz, V. & Buchberger, A. Imbalances in p97 co-factor interactions in human proteinopathy. EMBO Rep. 11, 479–485 (2010).

  16. 16

    Weihl, C. C., Dalal, S., Pestronk, A. & Hanson, P. I. Inclusion body myopathy-associated mutations in p97/VCP impair endoplasmic reticulum-associated degradation. Hum. Mol. Genet. 15, 189–199 (2006).

  17. 17

    Ye, Y., Meyer, H. H. & Rapoport, T. A. Function of the p97-Ufd1-Npl4 complex in retrotranslocation from the ER to the cytosol: dual recognition of nonubiquitinated polypeptide segments and polyubiquitin chains. J. Cell Biol. 162, 71–84 (2003).

  18. 18

    Ramadan, K. et al. Cdc48/p97 promotes reformation of the nucleus by extracting the kinase Aurora B from chromatin. Nature 450, 1258–1262 (2007).

  19. 19

    Keller, A., Eng, J., Zhang, N., Li, X. J. & Aebersold, R. A uniform proteomics MS/MS analysis platform utilizing open XML file formats. Mol. Syst. Biol. 1, 0017 (2005).

  20. 20

    Iwawaki, T., Akai, R., Kohno, K. & Miura, M. A transgenic mouse model for monitoring endoplasmic reticulum stress. Nat. Med. 10, 98–102 (2004).

  21. 21

    Madsen, L. et al. Ubxd1 is a novel co-factor of the human p97 ATPase. Int. J. Biochem. Cell Biol. 40, 2927–2942 (2008).

  22. 22

    Parton, R. G. & Simons, K. The multiple faces of caveolae. Nat. Rev. Mol. Cell Biol. 8, 185–194 (2007).

  23. 23

    Hayer, A., Stoeber, M., Bissig, C. & Helenius, A. Biogenesis of caveolae: stepwise assembly of large caveolin and cavin complexes. Traffic 11, 361–382 (2010).

  24. 24

    Scheiffele, P. et al. Caveolin-1 and -2 in the exocytic pathway of MDCK cells. J. Cell Biol. 140, 795–806 (1998).

  25. 25

    Monier, S. et al. VIP21-caveolin, a membrane protein constituent of the caveolar coat, oligomerizes in vivo and in vitro. Mol. Biol. Cell 6, 911–927 (1995).

  26. 26

    Tagawa, A. et al. Assembly and trafficking of caveolar domains in the cell: caveolae as stable, cargo-triggered, vesicular transporters. J. Cell Biol. 170, 769–779 (2005).

  27. 27

    Mundy, D. I., Machleidt, T., Ying, Y. S., Anderson, R. G. & Bloom, G. S. Dual control of caveolar membrane traffic by microtubules and the actin cytoskeleton. J. Cell Sci. 115, 4327–4339 (2002).

  28. 28

    Haglund, K., Di Fiore, P. P. & Dikic, I. Distinct monoubiquitin signals in receptor endocytosis. Trends Biochem. Sci. 28, 598–603 (2003).

  29. 29

    Sargiacomo, M. et al. Oligomeric structure of caveolin: implications for caveolae membrane organization. Proc. Natl Acad. Sci. USA 92, 9407–9411 (1995).

  30. 30

    Pol, A. et al. Cholesterol and fatty acids regulate dynamic caveolin trafficking through the Golgi complex and between the cell surface and lipid bodies. Mol. Biol. Cell 16, 2091–2105 (2005).

  31. 31

    Rape, M. et al. Mobilization of processed, membrane-tethered SPT23 transcription factor by CDC48(UFD1/NPL4), a ubiquitin-selective chaperone. Cell 107, 667–677 (2001).

  32. 32

    Lee, H. et al. Caveolin-1 mutations (P132L and null) and the pathogenesis of breast cancer: caveolin-1 (P132L) behaves in a dominant-negative manner and caveolin-1 (−/−) null mice show mammary epithelial cell hyperplasia. Am. J. Pathol. 161, 1357–1369 (2002).

  33. 33

    Chou, T. F. et al. Reversible inhibitor of p97, DBeQ, impairs both ubiquitin-dependent and autophagic protein clearance pathways. Proc. Natl Acad. Sci. USA 108, 4834–4839 (2011).

  34. 34

    Ren, J., Pashkova, N., Winistorfer, S. & Piper, R. C. DOA1/UFD3 plays a role in sorting ubiquitinated membrane proteins into multivesicular bodies. J. Biol. Chem. 283, 21599–21611 (2008).

  35. 35

    Weihl, C. C., Miller, S. E., Hanson, P. I. & Pestronk, A. Transgenic expression of inclusion body myopathy associated mutant p97/VCP causes weakness and ubiquitinated protein inclusions in mice. Hum. Mol. Genet. 16, 919–928 (2007).

  36. 36

    Minetti, C. et al. Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy. Nat. Genet. 18, 365–368 (1998).

  37. 37

    Goode, A. & Layfield, R. Recent advances in understanding the molecular basis of Paget disease of bone. J. Clin. Pathol. 63, 199–203 (2010).

  38. 38

    Skibinski, G. et al. Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia. Nat. Genet. 37, 806–808 (2005).

  39. 39

    Bolte, S. & Cordelieres, F. P. A guided tour into subcellular colocalization analysis in light microscopy. J. Microsc. 224, 213–232 (2006).

  40. 40

    MacLean, B., Eng, J. K., Beavis, R. C. & McIntosh, M. General framework for developing and evaluating database scoring algorithms using the TANDEM search engine. Bioinformatics 22, 2830–2832 (2006).

Download references

Acknowledgements

We thank A. Helenius, M. Kaiser, P. Hanson and A. Pestronk for discussions and reagents, G. Dey for image analysis software, C. Brasseur and G. Csucs for technical help, and R. Deshaies for sharing results before publication. This work was supported by grants from the ETH (26/05-2 and 25/08-1), the DFG priority programme SPP1365/2 and the Fondation Suisse de recherche sur les maladies musculaires (to H.M.). C.C.W. is supported by the NIH (R01 AG031867) and the Muscular Dystrophy Association.

Author information

D.R. generated cells, isolated VCP complexes and carried out the biochemical analyses with help from P.K., S.S. and S.B., and M.V. and M.B. carried out microscopy. A.H. helped design experiments and carried out the co-localization analysis. H.L, T.G., M.G. and R.A. carried out mass spectrometry analysis. C.L., R.H.B. and C.C.W. carried out electron microscopy and analysis of patient material. H.M. conceived the project and wrote the manuscript.

Correspondence to Conrad C. Weihl or Hemmo Meyer.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary Information

Supplementary Information (PDF 2146 kb)

Supplementary Table 1

Supplementary Information (XLS 20 kb)

Supplementary Table 2

Supplementary Information (XLSX 10 kb)

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Ritz, D., Vuk, M., Kirchner, P. et al. Endolysosomal sorting of ubiquitylated caveolin-1 is regulated by VCP and UBXD1 and impaired by VCP disease mutations. Nat Cell Biol 13, 1116–1123 (2011) doi:10.1038/ncb2301

Download citation

Further reading